A randomized, double-blind, placebo-controlled larger phase 2b trial of RGRN-305
Latest Information Update: 12 Oct 2023
At a glance
- Drugs RGRN-305 (Primary)
- Indications Hidradenitis suppurativa
- Focus Therapeutic Use
Most Recent Events
- 12 Oct 2023 New trial record